Insights from Multi-Target Molecular Docking and A549–BEAS-2B Comparative Assays: Valyltryptophan Dipeptide
- 1İSTANBUL ÜNİVERSİTESİ, FEN FAKÜLTESİ
Abstract
Cancer, one of the leading causes of death worldwide, continues to be one of the most important areas where scientists are working to develop treatments. In particular, targeting dysregulated signaling pathways is seen as a key strategy for developing effective anticancer treatments. In this study, a combined in silico and in vitro approach was employed to assess the anticancer potential of Valyltryptophan (VW) dipeptide. Molecular docking analyses were conducted with five important proteins involved in oncogenic signaling—EGFR, HER2, mTOR, Akt1, and PI3K—to predict their binding modes and docking scores. Among all targets, the most favorable predicted docking score was obtained for Akt1 (–8.5 kcal/mol), with hydrogen bonding and hydrophobic contacts within the binding pocket. To complement the computational analysis, MTT assays were performed using human lung carcinoma cells (A549) and normal bronchial epithelial cells (BEAS-2B). VW reduced the MTT-derived metabolic viability of A549 cells to 51.9% of control at the highest tested concentration (1 mg/mL, 3.30 mM) after 48 h; because the 50% threshold was not crossed and the concentration–response relationship was non-monotonic, the IC50 is reported as >1 mg/mL. BEAS-2B viability remained above 70% at all tested concentrations. Two-way ANOVA indicated a significant cell type × concentration interaction (p<0.0001), although the difference between the two cell lines depended on concentration and exposure time. Overall, these results are preliminary and hypothesis-generating; they identify VW as a candidate with predicted multi-target binding potential that warrants evaluation with orthogonal viability, mechanistic, and in vivo studies
Related
- Structural insights into an aptainhibitor of the SARS-CoV-2 E protein using molecular docking, molecular dynamics, and biophysical analyses
- Phytochemical Profiling and Anticancer Potential of Ipomoea hederifolia L. Root Extract: LC-MS Characterization and Molecular Docking Insights.
- Structural conservation of the gabapentinoid binding site in human and Caenorhabditis elegans α2δ subunits: a docking and molecular dynamics perspective
- Special Issue “Molecular Mechanism Discovery of the Bioactive Phytochemicals against Different Diseases Based on Network Pharmacology and Molecular Docking, 2nd Edition”
- QSAR-Guided In Silico Design of Piperazinylanthranilamide Factor Xa Inhibitors: Applicability-Domain Assessment, ADMET Profiling, Molecular Docking, Molecular Dynamics, and MM/GBSA
BibTeX
@article{akman2026insights,
title = {{Insights from Multi-Target Molecular Docking and A549–BEAS-2B Comparative Assays: Valyltryptophan Dipeptide}},
author = {Gizem Akman and Bilge Bıçak},
journal = {Cumhuriyet Science Journal},
year = {2026},
month = oct,
doi = {10.17776/csj.1845311},
url = {https://doi.org/10.17776/csj.1845311},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Insights from Multi-Target Molecular Docking and A549–BEAS-2B Comparative Assays: Valyltryptophan Dipeptide
AU - Gizem Akman
AU - Bilge Bıçak
PY - 2026
DA - 2026/10/01
JO - Cumhuriyet Science Journal
DO - 10.17776/csj.1845311
UR - https://doi.org/10.17776/csj.1845311
AB - Cancer, one of the leading causes of death worldwide, continues to be one of the most important areas where scientists are working to develop treatments. In particular, targeting dysregulated signaling pathways is seen as a key strategy for developing effective anticancer treatments. In this study, a combined in silico and in vitro approach was employed to assess the anticancer potential of Valyltryptophan (VW) dipeptide. Molecular docking analyses were conducted with five important proteins involved in oncogenic signaling—EGFR, HER2, mTOR, Akt1, and PI3K—to predict their binding modes and docking scores. Among all targets, the most favorable predicted docking score was obtained for Akt1 (–8.5 kcal/mol), with hydrogen bonding and hydrophobic contacts within the binding pocket. To complement the computational analysis, MTT assays were performed using human lung carcinoma cells (A549) and normal bronchial epithelial cells (BEAS-2B). VW reduced the MTT-derived metabolic viability of A549 cells to 51.9% of control at the highest tested concentration (1 mg/mL, 3.30 mM) after 48 h; because the 50% threshold was not crossed and the concentration–response relationship was non-monotonic, the IC50 is reported as >1 mg/mL. BEAS-2B viability remained above 70% at all tested concentrations. Two-way ANOVA indicated a significant cell type × concentration interaction (p<0.0001), although the difference between the two cell lines depended on concentration and exposure time. Overall, these results are preliminary and hypothesis-generating; they identify VW as a candidate with predicted multi-target binding potential that warrants evaluation with orthogonal viability, mechanistic, and in vivo studies
SN - 2587-2680
SN - 2587-246X
ER -